3 months clinical follow-up | n = 40 | % |
Readmission for ACS | 4 | 10% |
Arrythmias | 2 | 5% |
Heart failure | 1 | 2.5% |
Stroke/TIA | 0 | 0 |
New Myocardial Infarction | 0 | 0 |
Cardiac mortality | 0 | 0 |